CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) earnings date, results and what the price requires
NYSE · SEC CIK 0001100682 · SEC filings checked Oct 17, 2026
Next report
Nov 4, 2026
Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$300.15
Polygon.io daily close, Oct 16, 2026. End of day, not live.
Trailing diluted EPS
$-4.80
Sum of quarters ending Jun 27, 2026, Mar 28, 2026, Dec 27, 2025, Sep 27, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 27, 2026 | Aug 5, 2026 | $1.00B | $-1.5M | $-0.03 | Filing |
| Mar 28, 2026 | May 7, 2026 | $995.8M | $-14.8M | $-0.30 | Filing |
| Dec 27, 2025 | Jan 13, 2026 | $994.2M | $-276.6M | $-5.57 | Filing |
| Sep 27, 2025 | Nov 5, 2025 | $1.00B | $54.4M | $1.10 | Filing |
| Jun 28, 2025 | Aug 6, 2025 | $1.03B | $52.3M | $1.06 | Filing |
| Mar 29, 2025 | May 7, 2025 | $984.2M | $25.5M | $0.50 | Filing |
| Dec 28, 2024 | Feb 19, 2025 | $1.00B | $-214.5M | $-4.17 | Filing |
| Sep 28, 2024 | Nov 6, 2024 | $1.01B | $69.7M | $1.33 | Filing |
What would CHARLES RIVER LABORATORIES INTERNATIONAL, INC. have to report for its valuation to change?
Trailing earnings are negative, so a price-to-earnings reverse model does not apply. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.